Michael Sarcone
Stock Analyst at Jefferies
(n/a)
# 4,900
Out of 5,058 analysts
8
Total ratings
n/a
Success rate
-36.38%
Average return
Main Sectors:
Stocks Rated by Michael Sarcone
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSP Inspire Medical Systems | Downgrades: Hold | $160 → $85 | $83.43 | +1.88% | 1 | Oct 24, 2025 | |
| ALGN Align Technology | Downgrades: Hold | $215 → $140 | $133.68 | +4.73% | 1 | Oct 10, 2025 | |
| EDAP EDAP TMS | Downgrades: Hold | $8 → $2 | $2.23 | -10.31% | 2 | Apr 4, 2025 | |
| PRCT PROCEPT BioRobotics | Initiates: Hold | $95 | $27.93 | +240.14% | 1 | Nov 14, 2024 | |
| GKOS Glaukos | Upgrades: Buy | $84 → $125 | $96.49 | +29.55% | 1 | May 6, 2024 | |
| PROF Profound Medical | Downgrades: Equal-Weight | $5.5 → $10 | $6.02 | +66.11% | 1 | Mar 21, 2023 | |
| AXGN Axogen | Assumes: Buy | $15 | $25.26 | -40.62% | 1 | Nov 11, 2022 |
Inspire Medical Systems
Oct 24, 2025
Downgrades: Hold
Price Target: $160 → $85
Current: $83.43
Upside: +1.88%
Align Technology
Oct 10, 2025
Downgrades: Hold
Price Target: $215 → $140
Current: $133.68
Upside: +4.73%
EDAP TMS
Apr 4, 2025
Downgrades: Hold
Price Target: $8 → $2
Current: $2.23
Upside: -10.31%
PROCEPT BioRobotics
Nov 14, 2024
Initiates: Hold
Price Target: $95
Current: $27.93
Upside: +240.14%
Glaukos
May 6, 2024
Upgrades: Buy
Price Target: $84 → $125
Current: $96.49
Upside: +29.55%
Profound Medical
Mar 21, 2023
Downgrades: Equal-Weight
Price Target: $5.5 → $10
Current: $6.02
Upside: +66.11%
Axogen
Nov 11, 2022
Assumes: Buy
Price Target: $15
Current: $25.26
Upside: -40.62%